Literature DB >> 22202090

The role of tumor-associated macrophage in tumor progression.

Koji Fukuda1, Aya Kobayashi, Kounosuke Watabe.   

Abstract

The tumor progression is not only regulated by metastasis promoting and suppressing genes in cancer cells but it is also strongly influenced by the interaction between cancer cells and the stromal cells. An abundance of inflammatory mediators and leukocytes has been known to promote cancer metastasis, and tumor associated macrophages (TAM) are the key players in the link between inflammation and cancer. TAM are derived from peripheral blood monocytes that are recruited into the tumor by inflammatory chemokines. Upon activation by cancer cells, TAM gain the ability of pro-tumoral functions including expression of various growth factors, promotion of angiogenesis and suppression of adaptive immunity, and many of these factors also play critical roles in cancer metastasis. In this review, we will summarize the recent information about the function of TAM in the inflammatory micro-environment of solid tumors and discuss the potential targets for future therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22202090     DOI: 10.2741/s299

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  30 in total

1.  Deacetylation by SIRT1 Reprograms Inflammation and Cancer.

Authors:  Tie Fu Liu; Charles E McCall
Journal:  Genes Cancer       Date:  2013-03

2.  Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development.

Authors:  Yuchen Liu; Luming Zhao; Dameng Li; Yuan Yin; Chen-Yu Zhang; Jing Li; Yujing Zhang
Journal:  Protein Cell       Date:  2013-11-07       Impact factor: 14.870

3.  CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy.

Authors:  Bingyu Li; Lijun Xu; Chenyu Pi; Yanxin Yin; Kun Xie; Fei Tao; Renhao Li; Hua Gu; Jianmin Fang
Journal:  Oncoimmunology       Date:  2017-10-12       Impact factor: 8.110

4.  Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signaling.

Authors:  Fahed Hakim; Yang Wang; Shelley X L Zhang; Jiamao Zheng; Esma S Yolcu; Alba Carreras; Abdelnaby Khalyfa; Haval Shirwan; Isaac Almendros; David Gozal
Journal:  Cancer Res       Date:  2014-01-21       Impact factor: 12.701

5.  Endostatin reverses immunosuppression of the tumor microenvironment in lung carcinoma.

Authors:  Xiaolin Liu; Weiwei Nie; Qi Xie; Guoling Chen; Xingyu Li; Yanrui Jia; Beibei Yin; Xun Qu; Yan Li; Jing Liang
Journal:  Oncol Lett       Date:  2017-11-21       Impact factor: 2.967

6.  FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages.

Authors:  Jing-Bo Yang; Zhi-Bin Zhao; Qing-Zhi Liu; Tai-Dou Hu; Jie Long; Kai Yan; Zhe-Xiong Lian
Journal:  Oncogene       Date:  2017-12-14       Impact factor: 9.867

7.  Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies.

Authors:  Marie Duhamel; Mélanie Rose; Franck Rodet; Adriana Natalia Murgoci; Lea Zografidou; Anne Régnier-Vigouroux; Fabien Vanden Abeele; Firas Kobeissy; Serge Nataf; Laurent Pays; Maxence Wisztorski; Dasa Cizkova; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2018-03-12       Impact factor: 5.911

8.  Anti-inflammatory macrophages activate invasion in pancreatic adenocarcinoma by increasing the MMP9 and ADAM8 expression.

Authors:  Pauli Puolakkainen; Aino Koski; Sanna Vainionpää; Zhanlong Shen; Heikki Repo; Esko Kemppainen; Harri Mustonen; Hanna Seppänen
Journal:  Med Oncol       Date:  2014-02-14       Impact factor: 3.064

Review 9.  TRP channels and STIM/ORAI proteins: sensors and effectors of cancer and stroma cell migration.

Authors:  N Nielsen; O Lindemann; A Schwab
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

10.  Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial.

Authors:  King L Tan; David W Scott; Fangxin Hong; Brad S Kahl; Richard I Fisher; Nancy L Bartlett; Ranjana H Advani; Rena Buckstein; Lisa M Rimsza; Joseph M Connors; Christian Steidl; Leo I Gordon; Sandra J Horning; Randy D Gascoyne
Journal:  Blood       Date:  2012-09-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.